01
2024
-
07
2022
Received A-round investment to accelerate project R&D and clinical trials
ZVS101e injection obtained IND approvals from China NMPA and U.S. FDA
ZVS203e injection received FDA orphan drug designation
Hot News
undefined
CHIGENOVO Co., Ltd. is an ophthalmic gene therapy company, a national high-tech enterprise focusing on genetic diagnosis of genetic eye diseases and the development of gene therapy drugs. It is committed to providing "one-stop" services for patients with genetic eye diseases.
HUATAO GROUP
Contact us
Telephone:400-6006223 010-82071936
Website:en.chinagene.cc
Address: Floor 4, Area D, Building 1, No.27 Life Garden Road, Zhongguancun Life Science Park, Changping District, Beijing
WeChat subscription account
